T1	PROC 1 7	Enemas
#1	AnnotatorNotes T1	C0014268; Administration of enema; Therapeutic or Preventive Procedure
T2	PROC 556 569	aleatorizados
#2	AnnotatorNotes T2	C0034656; Randomization; Research Activity
T3	CHEM 11 43	factor de crecimiento epidérmico
#3	AnnotatorNotes T3	C0242275; epidermal growth factor; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T4	PROC 1213 1224	histológica
#4	AnnotatorNotes T4	C0344441; Histology Procedure; Laboratory Procedure
T5	DISO 75 91	colitis ulcerosa
#5	AnnotatorNotes T5	C0009324; Ulcerative Colitis; Disease or Syndrome
T6	PROC 761 769	tratados
#6	AnnotatorNotes T6	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T7	DISO 120 136	colitis ulcerosa
#7	AnnotatorNotes T7	C0009324; Ulcerative Colitis; Disease or Syndrome
T8	DISO 144 175	enfermedad inflamatoria crónica
#8	AnnotatorNotes T8	C1290886; Chronic inflammatory disorder; Disease or Syndrome
T9	ANAT 218 234	mucosa del colon
#9	AnnotatorNotes T9	C0227349; Colonic mucous membrane; Body Part, Organ, or Organ Component
T10	CHEM 1314 1346	factor de crecimiento epidérmico
#10	AnnotatorNotes T10	C0242275; epidermal growth factor; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T11	CHEM 259 291	factor de crecimiento epidérmico
#11	AnnotatorNotes T11	C0242275; epidermal growth factor; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T12	DISO 364 377	manifestación
#12	AnnotatorNotes T12	C0037088; Signs and Symptoms; Sign or Symptom
T13	PROC 335 340	enema
#13	AnnotatorNotes T13	C0014268; Administration of enema; Therapeutic or Preventive Procedure
T14	PROC 346 357	tratamiento
#14	AnnotatorNotes T14	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T15	DISO 410 420	enfermedad
#15	AnnotatorNotes T15	C0012634; Disease; Disease or Syndrome
T16	PROC 459 500	evaluar la eficacia y perfil de seguridad
#16	AnnotatorNotes T16	C0511730; Identify product efficacy and safety issues; Health Care Activity
T17	PROC 604 615	tratamiento
#17	AnnotatorNotes T17	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T18	PROC 656 662	enemas
#18	AnnotatorNotes T18	C0014268; Administration of enema; Therapeutic or Preventive Procedure
T19	CHEM 675 707	factor de crecimiento epidérmico
#19	AnnotatorNotes T19	C0242275; epidermal growth factor; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T20	PROC 774 788	enemas placebo
T21	CHEM 877 887	mesalacina
#20	AnnotatorNotes T21	C0127615; mesalamine; Organic Chemical · Pharmacologic Substance
T22	CHEM 935 945	mesalacina
#21	AnnotatorNotes T22	C0127615; mesalamine; Organic Chemical · Pharmacologic Substance
T23	PROC 949 955	enemas
#22	AnnotatorNotes T23	C0014268; Administration of enema; Therapeutic or Preventive Procedure
T24	PROC 1063 1074	tratamiento
#23	AnnotatorNotes T24	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T25	DISO 1166 1176	enfermedad
#24	AnnotatorNotes T25	C0012634; Disease; Disease or Syndrome
T26	PROC 1199 1210	endoscópica
#25	AnnotatorNotes T26	C0014245; Endoscopy (procedure); Diagnostic Procedure
T27	DISO 1265 1275	enfermedad
#26	AnnotatorNotes T27	C0012634; Disease; Disease or Syndrome
T28	CHEM 1498 1530	factor de crecimiento epidérmico
#27	AnnotatorNotes T28	C0242275; epidermal growth factor; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T29	CHEM 1371 1381	mesalacina
#28	AnnotatorNotes T29	C0127615; mesalamine; Organic Chemical · Pharmacologic Substance
T30	PROC 1382 1387	enema
#29	AnnotatorNotes T30	C0014268; Administration of enema; Therapeutic or Preventive Procedure
T31	PROC 1390 1397	placebo
#30	AnnotatorNotes T31	C0032042; Placebos; Therapeutic or Preventive Procedure
T32	DISO 1614 1624	enfermedad
#31	AnnotatorNotes T32	C0012634; Disease; Disease or Syndrome
T33	DISO 1663 1682	síntomas digestivos
#32	AnnotatorNotes T33	C0426576; Gastrointestinal symptom; Sign or Symptom
T34	PROC 1710 1721	tratamiento
#33	AnnotatorNotes T34	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T35	DISO 1730 1744	evento adverso
#34	AnnotatorNotes T35	C0877248; Adverse event; Pathologic Function
T36	CHEM 1877 1909	factor de crecimiento epidérmico
#35	AnnotatorNotes T36	C0242275; epidermal growth factor; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T37	DISO 1968 1984	colitis ulcerosa
#36	AnnotatorNotes T37	C0009324; Ulcerative Colitis; Disease or Syndrome
T38	PROC 2088 2094	enemas
#37	AnnotatorNotes T38	C0014268; Administration of enema; Therapeutic or Preventive Procedure
T39	CHEM 2098 2130	factor de crecimiento epidérmico
#38	AnnotatorNotes T39	C0242275; epidermal growth factor; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T40	ANAT 33 43	epidérmico
#39	AnnotatorNotes T40	C0014520; Epidermis; Tissue | C1284118; Entire epidermis; Tissue
T41	ANAT 281 291	epidérmico
#40	AnnotatorNotes T41	C0014520; Epidermis; Tissue | C1284118; Entire epidermis; Tissue
T42	CHEM 508 524	solución viscosa
#41	AnnotatorNotes T42	C3857177; Viscous Solutions; Substance
T43	ANAT 697 707	epidérmico
#42	AnnotatorNotes T43	C0014520; Epidermis; Tissue | C1284118; Entire epidermis; Tissue
T44	CHEM 721 737	solución viscosa
#43	AnnotatorNotes T44	C3857177; Viscous Solutions; Substance
T45	CHEM 811 827	solución viscosa
#44	AnnotatorNotes T45	C3857177; Viscous Solutions; Substance
T46	ANAT 1336 1346	epidérmico
#45	AnnotatorNotes T46	C0014520; Epidermis; Tissue | C1284118; Entire epidermis; Tissue
T47	ANAT 1520 1530	epidérmico
#46	AnnotatorNotes T47	C0014520; Epidermis; Tissue | C1284118; Entire epidermis; Tissue
T48	ANAT 1899 1909	epidérmico
#47	AnnotatorNotes T48	C0014520; Epidermis; Tissue | C1284118; Entire epidermis; Tissue
T49	ANAT 2120 2130	epidérmico
#48	AnnotatorNotes T49	C0014520; Epidermis; Tissue | C1284118; Entire epidermis; Tissue
T50	Duration 168 175	crónica
#49	AnnotatorNotes T50	C0205191; chronic; Temporal Concept
T51	Form 508 516	solución
#50	AnnotatorNotes T51	C1382100; Solution Dosage Form; Biomedical or Dental Material
T52	LIVB 573 582	pacientes
#51	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group
T53	Frequency 616 622	diario
T54	Duration 631 638	14 días
T55	Dose 666 671	10 mg
T56	Dose 711 717	100 mL
T57	Form 721 729	solución
#52	AnnotatorNotes T57	C1382100; Solution Dosage Form; Biomedical or Dental Material
T58	Form 811 819	solución
#53	AnnotatorNotes T58	C1382100; Solution Dosage Form; Biomedical or Dental Material
T59	Dose 860 865	1,2 g
T60	Frequency 866 873	diarios
T61	Route 888 892	oral
#54	AnnotatorNotes T61	C1527415; Oral Route of Drug administration; Functional Concept
T62	LIVB 921 930	pacientes
#55	AnnotatorNotes T62	C0030705; Patients; Patient or Disabled Group
T63	Dose 959 970	3g / 100 mL
T66	Duration 1044 1059	las dos semanas
T67	LIVB 1289 1298	pacientes
#56	AnnotatorNotes T67	C0030705; Patients; Patient or Disabled Group
T68	LIVB 1690 1699	pacientes
#57	AnnotatorNotes T68	C0030705; Patients; Patient or Disabled Group
T69	Neg_cue 1723 1729	Ningún
T71	LIVB 2044 2053	pacientes
#58	AnnotatorNotes T71	C0030705; Patients; Patient or Disabled Group
T78	DEVI 774 780	enemas
#59	AnnotatorNotes T78	C0180734; Enema bag; Medical Device
T83	ANAT 1672 1682	digestivos
#60	AnnotatorNotes T83	C0012240; Gastrointestinal system; Body System
T64	Quantifier_or_Qualifier 92 101	izquierda
#61	AnnotatorNotes T64	C0205091; Left; Spatial Concept
T65	Quantifier_or_Qualifier 378 387	izquierda
#62	AnnotatorNotes T65	C0205091; Left; Spatial Concept
T70	Quantifier_or_Qualifier 388 403	leve o moderada
T72	Observation 1250 1275	remisión de la enfermedad
#63	AnnotatorNotes T72	C0544452; Disease remission; Finding
T73	Observation 60 68	remisión
#64	AnnotatorNotes T73	C0544452; Disease remission; Finding
T74	Observation 1953 1961	remisión
#65	AnnotatorNotes T74	C0544452; Disease remission; Finding
T75	Observation 1013 1030	respuesta clínica
#66	AnnotatorNotes T75	C4055223; Clinical Response; Finding
T76	Observation 1191 1198	mejoría
#67	AnnotatorNotes T76	C0184511; Improved; Finding (?)
A1	Assertion T35 Negated
R1	Used_for Arg1:T3 Arg2:T1
R2	Has_Quantifier_or_Qualifier Arg1:T5 Arg2:T64
R3	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T65
R4	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T70
R6	Has_Duration_or_Interval Arg1:T8 Arg2:T50
R7	Used_for Arg1:T11 Arg2:T13
R8	Has_Drug_Form Arg1:T42 Arg2:T51
R9	Experiences Arg1:T52 Arg2:T17
R10	Has_Frequency Arg1:T17 Arg2:T53
R11	Has_Duration_or_Interval Arg1:T17 Arg2:T54
R12	Has_Dose_or_Strength Arg1:T19 Arg2:T55
R13	Has_Dose_or_Strength Arg1:T44 Arg2:T56
R14	Has_Drug_Form Arg1:T44 Arg2:T57
R15	Used_for Arg1:T19 Arg2:T18
R16	Combined_with Arg1:T19 Arg2:T44
R17	Used_for Arg1:T78 Arg2:T20
R18	Has_Drug_Form Arg1:T45 Arg2:T58
R19	Used_for Arg1:T45 Arg2:T20
R20	Has_Frequency Arg1:T21 Arg2:T60
R21	Has_Route_or_Mode Arg1:T21 Arg2:T61
R22	Has_Dose_or_Strength Arg1:T21 Arg2:T59
R23	Experiences Arg1:T62 Arg2:T23
R24	Used_for Arg1:T22 Arg2:T23
R25	Has_Dose_or_Strength Arg1:T22 Arg2:T63
R26	After Arg1:T75 Arg2:T66
R27	Has_Duration_or_Interval Arg1:T24 Arg2:T66
R28	After Arg1:T76 Arg2:T66
R29	Experiences Arg1:T67 Arg2:T72
R30	Experiences Arg1:T67 Arg2:T27
R31	Experiences Arg1:T67 Arg2:T30
R32	Used_for Arg1:T29 Arg2:T30
R33	Experiences Arg1:T67 Arg2:T31
R34	Before Arg1:T24 Arg2:T26
R35	Before Arg1:T24 Arg2:T4
R38	Location_of Arg1:T83 Arg2:T33
R39	Experiences Arg1:T68 Arg2:T32
R40	Experiences Arg1:T68 Arg2:T33
R41	Experiences Arg1:T68 Arg2:T34
R42	Used_for Arg1:T28 Arg2:T34
R43	Overlap Arg1:T32 Arg2:T33
R44	Negation Arg1:T69 Arg2:T35
R46	Experiences Arg1:T71 Arg2:T38
R47	Used_for Arg1:T39 Arg2:T38
R48	Location_of Arg1:T9 Arg2:T7
R49	Overlap Arg1:T75 Arg2:T76
R50	After Arg1:T33 Arg2:T34	
R5	Before Arg1:T5 Arg2:T73	
R51	After Arg1:T75 Arg2:T24	
R52	Before Arg1:T25 Arg2:T76	
R53	Before Arg1:T27 Arg2:T72	
R54	Before Arg1:T37 Arg2:T74	
R45	Before Arg1:T24 Arg2:T76	
R55	Experiences Arg1:T67 Arg2:T10	
R36	Experiences Arg1:T67 Arg2:T29	
T77	LIVB 594 615	grupos de tratamiento
#68	AnnotatorNotes T77	C5205742; Treatment Group; Population Group
R37	Experiences Arg1:T77 Arg2:T17	
R56	Before Arg1:T2 Arg2:T17	
T79	Observation 239 254	efecto positivo
#69	AnnotatorNotes T79	C4049461; Unexpected beneficial therapeutic response; Finding (?)
R57	Causes Arg1:T11 Arg2:T79	
#70	AnnotatorNotes T70	C1299392; Mild to moderate; Qualitative Concept
R58	Causes Arg1:T15 Arg2:T12	
A2	Experiencer T52 Patient
A3	Experiencer T77 Patient
A4	Experiencer T62 Patient
A5	Experiencer T67 Patient
A6	Experiencer T68 Patient
A7	Experiencer T71 Patient
